These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2848432)

  • 1. [Oral vaccination with live attenuated rotavirus].
    Escobar Castro H; Perdomo Giraldi M; Tamáriz-Martel Moreno A; Suárez Cortina L
    An Esp Pediatr; 1988 Jun; 28(6):527-9. PubMed ID: 2848432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
    De Vos B; Han HH; Bouckenooghe A; Debrus S; Gillard P; Ward R; Cheuvart B
    Pediatr Infect Dis J; 2009 Apr; 28(4):261-6. PubMed ID: 19289978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.
    Clark HF; Bernstein DI; Dennehy PH; Offit P; Pichichero M; Treanor J; Ward RL; Krah DL; Shaw A; Dallas MJ; Laura D; Eiden JJ; Ivanoff N; Kaplan KM; Heaton P
    J Pediatr; 2004 Feb; 144(2):184-90. PubMed ID: 14760258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic background for the need of rotavirus vaccine in Finland. Preliminary experience of RIT 4237 strain of live attenuated rotavirus vaccine in adults.
    Vesikari T; Mäki M; Isolauri E
    Dev Biol Stand; 1983; 53():229-36. PubMed ID: 6307778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study.
    Phua KB; Lim FS; Lau YL; Nelson EA; Huang LM; Quak SH; Lee BW; Teoh YL; Tang H; Boudville I; Oostvogels LC; Suryakiran PV; Smolenov IV; Han HH; Bock HL
    Vaccine; 2009 Oct; 27(43):5936-41. PubMed ID: 19679216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response of pregnant cows to bovine rotavirus immunization.
    Saif LJ; Smith KL; Landmeier BJ; Bohl EH; Theil KW; Todhunter DA
    Am J Vet Res; 1984 Jan; 45(1):49-58. PubMed ID: 6322624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants.
    Bernstein DI; Sack DA; Reisinger K; Rothstein E; Ward RL
    J Infect Dis; 2002 Nov; 186(10):1487-9. PubMed ID: 12404166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.
    Block SL; Vesikari T; Goveia MG; Rivers SB; Adeyi BA; Dallas MJ; Bauder J; Boslego JW; Heaton PM;
    Pediatrics; 2007 Jan; 119(1):11-8. PubMed ID: 17200266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
    Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants.
    Zoppi G; Ferrarini G; Rigolin F; Bogaerts H; André FE
    Helv Paediatr Acta; 1986 Aug; 41(3):203-8. PubMed ID: 3019954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of shedding of the RIX4414 live attenuated rotavirus vaccine administered to adult volunteers.
    Zibrik L; Dove W; McArdle F; Rustom R; Hart CA; Jackson MJ
    Arch Virol; 2007; 152(10):1951-4. PubMed ID: 17623269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short report on highlights of world-wide development of RIX4414: a Latin American experience.
    Linhares AC; Ruiz-Palacios GM; Guerrero ML; Salinas B; Perez-Schael I; Clemens SA; Innis B; Yarzabal JP; Vespa G; Cervantes Y; Hardt K; De Vos B
    Vaccine; 2006 May; 24(18):3784-5. PubMed ID: 16098636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
    Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
    Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A short report on clinical evaluation of RIX4414: highlights of world-wide development.
    De Vos B; Delem A; Hardt K; Bock HL; Meurice F; Innis B
    Vaccine; 2006 May; 24(18):3777-8. PubMed ID: 16584814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.